ANGELAB consortium brings together 15 partners from 7 EU member states (Spain, Germany, Cyprus, United Kingdom, Austria, France, and Poland). The project has a clear European dimension as it is depicted in the following figure.
In order to achieve the described objectives, the consortium represents not only a RTD capability, but also has innovative SMEs that perform high quality R&D, hospitals represented by a Governmental institution and the involvement of the private sector to guarantee the subsequent exploitation of the results. This multidisciplinary consortium provides a holistic view of the problem that is crucial for the success of the project. Thus, the ANGELAB membership, including the organization type, is shown in the next table:
CING
NIPD7 companies (6 SMEs, 1 LE), 5 Institutes, 2 hospitals and a Health Care system
